Attenuating the solubility of carbohydrate-based drugs for improved delivery and targeting

CARB 99

Todd A. Houston, T.Houston@griffith.edu.au1, Brendan L. Wilkinson, Brendan.Wilkinson@student.griffith.edu.au2, Sabina Quader2, Laurent F. Bornaghi1, Sue E. Boyd2, Sally-Ann Poulsen2, and Ian D. Jenkins2. (1) Institute for Glycomics, Griffith University, PMB 50 Gold Coast Mail Centre, Gold Coast, 9726, Australia, (2) Eskitis Institute for Cell and Molecular Therapies, Griffith University, 170 Kessels Rd, Nathan, 4111, Australia
Addition of carbohydrates and/or lipids to drugs offers opposing avenues to greatly alter their physicochemical properties.[1] In concert, glycolipids are an important class of bioactive compounds. Recently, we have described a "click-tailing" approach to a family of glycosylated benzenesulfonamides that display isozyme discrimination among the carbonic anhydrase (CA) family of enzymes.[2] The carbohydrate moiety should also improve aqueous solubility and decrease membrane permeability allowing the targeting of extracellular binding sites of CA isozymes overexpressed in solid tumors. In a complementary approach, we have also synthesized lipid derivatives of aminoglycosides using highly selective chemistry on these complex systems.[3] This modification was designed to improve membrane permeability against the waxy coat of Mycobacterium tuberculosis. Biological testing results on both sets of compounds will be discussed.

[1] Blanchfield, J.; Toth, I. Curr. Med. Chem. 2004, 11, 2375. [2] Wilkinson, B. L.; Bornaghi, L. F.; Houston, T. A.; Innocenti, A.; Supuran, C. T.; Poulsen, S.-A. J. Med. Chem. 2006, 49, 6539. [3] Quader, S.; Boyd, S. E.; Jenkins, I. D.; Houston, T. A. Org. Biomol.Chem. 2006, 4, 36.

 

Nucleic Acid Therapeutics
9:00 AM-11:45 AM, Wednesday, March 28, 2007 McCormick Place North -- Room N226, Level 2, Oral

Division of Carbohydrate Chemistry

The 233rd ACS National Meeting, Chicago, IL, March 25-29, 2007